Hypoalbuminemia, Coagulopathy, and Vascular Disease in COVID-19

Circ Res. 2020 Jul 17;127(3):400-401. doi: 10.1161/CIRCRESAHA.120.317173. Epub 2020 Jun 8.

Affiliations

¹ From the I Clinica Medica, Department of Clinical, Internal, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Italy (F.V., D.P., L.L., P.P.).
² Department of Public Health and Infectious Diseases, Sapienza University of Rome, Italy (G.C., G.D., A.O., M.V., C.M.M.).
³ Department of General Surgery Paride Stefanini, Sapienza University of Rome, Italy (R.C., F.A., F.R., F.P.).

PMID: 32508261
DOI: 10.1161/CIRCRESAHA.120.317173

No abstract available

Keywords: COVID-19; creatinine; hypoalbuminemia; thrombosis; vascular diseases.

Publication types

Letter
Observational Study

MeSH terms

Aged
Aged, 80 and over
Biomarkers / blood
Blood Coagulation Disorders / blood
Blood Coagulation Disorders / epidemiology*
COVID-19
Coronavirus Infections / blood
Coronavirus Infections / complications*
Female
Humans
Hypoalbuminemia / blood
Hypoalbuminemia / epidemiology*
Male
Middle Aged
Pandemics
Pneumonia, Viral / blood
Pneumonia, Viral / complications*
Vascular Diseases / blood
Vascular Diseases / epidemiology*

Substances

Biomarkers